Amryt Pharma Plc's ROA from the fourth quarter of 2021 to the fourth quarter of and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Amryt Pharma Plc's ROA in the fourth quarter of 2021?

However, within the Healthcare sector 267 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2021 from to 3341.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2021) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter
Y / Y Total Assets Change	150.67 %	57.44 %	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	0	0	0	0	0
Return On Assets (TTM)	0 %	0 %	0 %	0 %	0 %
AMYT's Total Ranking	# 3341	#	#	#	#
Total Assets (TTM) in million	1,316	816	816	816	525
Seq. Total Assets Change	61.24 %	0 %	0 %	55.46 %	1.27 %
Seq. Net Income Change	-	-	-	-	-

AMYT's 5 Years Annual ROA >> Back to AMYT Management Effectiveness >> Compare AMYT ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 94
Sector	# 268
Overall	# 3267

Return On Assets Statistics
High	Average	Low
0.12 %	0.12 %	0.12 %
(Dec 31 2021)

Financial Statements
Amryt Pharma Plc's Assets	$ 1,316 million	AMYT's Balance sheet
Amryt Pharma Plc's Income	$ 0 million	Quarterly AMYT's Income Statement
AMYT's Income by Division		See AMYT's Income by Division

Annual Return On Assets	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	FY	FY	FY
Y / Y Total Assets Change	150.67 %	-	-	-	-
Total Assets in million	1,316	525	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	1	-105	0	0	0
Annual Return On Assets	0.08 %	-19.91 %	-	-	-

AMYT's 5 Years Annual ROA >> Back to AMYT Management Effectiveness >> Compare AMYT ROA to its Competitors

Comment on AMYT's ROA in the fiscal year ending 2021

In the fiscal year 2021 ROA improved to 0.08 % compared to prior year, due to annual net income growth of % to $1.00 million, while value of Amryt Pharma Plc's overall assets grew just by 150.67 % to $1,315.79 million, compared to $1,315.79 a year before.

More Return On Assets Ratios
AMYT's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
AMYT's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for AMYT's Competitors
Subscribers only: Roa for Amryt Pharma Plc's Suppliers
Subscribers only: Return On Assets for AMYT's Customers

You may also want to know
AMYT's Roi	AMYT's Inventory Turnover Ratio	AMYT's Growth Rates	AMYT's Dividend Comparisons
	AMYT's Profitability Ratios	AMYT's Asset Turnover Ratio	AMYT's Dividend Growth
AMYT's Roe	AMYT's Valuation Ratios	AMYT's Financial Strength Ratios	AMYT's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2021, within Healthcare Sector

ROA

Date modified: 2023-03-22T13:18:58+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.